BR112022026201A2 - Antagonistas do receptor de glicocorticoide de indazol quaternários - Google Patents
Antagonistas do receptor de glicocorticoide de indazol quaternáriosInfo
- Publication number
- BR112022026201A2 BR112022026201A2 BR112022026201A BR112022026201A BR112022026201A2 BR 112022026201 A2 BR112022026201 A2 BR 112022026201A2 BR 112022026201 A BR112022026201 A BR 112022026201A BR 112022026201 A BR112022026201 A BR 112022026201A BR 112022026201 A2 BR112022026201 A2 BR 112022026201A2
- Authority
- BR
- Brazil
- Prior art keywords
- indazole
- quaternary
- receptor antagonists
- glucocorticoid receptor
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
ANTAGONISTAS DO RECEPTOR DE GLICOCORTICOIDE DE INDAZOL QUATERNÁRIOS. A presente invenção fornece compostos de Fórmula I ou II. Os compostos de Fórmula I ou II podem ser usados em Fórmulações farmacêuticas e podem ser usados para modular os receptores de glicocorticoides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063042188P | 2020-06-22 | 2020-06-22 | |
PCT/US2021/038218 WO2021262587A1 (en) | 2020-06-22 | 2021-06-21 | Quaternary indazole glucocorticoid receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022026201A2 true BR112022026201A2 (pt) | 2023-01-17 |
Family
ID=79281742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022026201A BR112022026201A2 (pt) | 2020-06-22 | 2021-06-21 | Antagonistas do receptor de glicocorticoide de indazol quaternários |
Country Status (13)
Country | Link |
---|---|
US (2) | US11787780B2 (pt) |
EP (1) | EP4168402A1 (pt) |
JP (1) | JP2023535279A (pt) |
KR (1) | KR20230027245A (pt) |
CN (1) | CN116113627A (pt) |
AU (1) | AU2021296163A1 (pt) |
BR (1) | BR112022026201A2 (pt) |
CA (1) | CA3187566A1 (pt) |
CO (1) | CO2023000627A2 (pt) |
IL (1) | IL298957A (pt) |
MX (1) | MX2022016445A (pt) |
TW (1) | TWI811710B (pt) |
WO (1) | WO2021262587A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230242514A1 (en) * | 2021-12-21 | 2023-08-03 | Corcept Therapeutics Incorporated | Bicyclic indazole glucocorticoid receptor antagonists |
WO2023213836A1 (en) * | 2022-05-05 | 2023-11-09 | Galapagos Nv | Sulfonamide compounds and pharmaceutical compositions thereof for the treatment of neurodegenerative disorders |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
WO2004074243A2 (en) | 2003-02-14 | 2004-09-02 | Wyeth | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
KR101135885B1 (ko) | 2004-01-09 | 2012-04-16 | 코어셉트 쎄라퓨틱스, 잉크. | 아자데칼린 글루코코르티코이드 수용체 조절제 |
ES2380990T3 (es) | 2004-02-23 | 2012-05-22 | Glaxo Group Limited | Derivados de azabiciclo[3.1.0]hexano útiles como moduladores de los receptores D3 de dopamina |
JP4931794B2 (ja) | 2004-03-09 | 2012-05-16 | コーセプト セラピューティクス, インコーポレイテッド | 縮合環アザデカリン糖質コルチコイド受容体モジュレーター |
ATE522519T1 (de) | 2008-03-20 | 2011-09-15 | Hoffmann La Roche | Pyrrolidinylderivate und anwendungen davon |
BR112012000657A2 (pt) | 2009-06-26 | 2016-11-16 | Panacea Biotec Ltd | novos azabicilohexanos |
SG187909A1 (en) | 2010-08-27 | 2013-03-28 | Corcept Therapeutics Inc | Pyridyl-amine fused azadecalin modulators |
US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
PT3074011T (pt) | 2013-11-25 | 2019-09-17 | Corcept Therapeutics Inc | Moduladores de receptores de glicocorticoides de azadecalina fundidas com octa-hidro |
WO2015155624A1 (en) | 2014-04-10 | 2015-10-15 | Pfizer Inc. | Dihydropyrrolopyrimidine derivatives |
CA2995325A1 (en) * | 2015-08-12 | 2017-02-16 | Mochida Pharmaceutical Co., Ltd. | Isothiazole derivative |
CN107021963A (zh) * | 2016-01-29 | 2017-08-08 | 北京诺诚健华医药科技有限公司 | 吡唑稠环类衍生物、其制备方法及其在治疗癌症、炎症和免疫性疾病上的应用 |
CN107286134B (zh) | 2016-04-11 | 2019-04-12 | 上海勋和医药科技有限公司 | 2,4-二取代嘧啶衍生物作为cdk抑制剂及其应用 |
CN116854693A (zh) | 2016-09-30 | 2023-10-10 | 阿沙纳生物科学公司 | P2x3和/或p2x2/3化合物及方法 |
CN106831787B (zh) | 2017-01-20 | 2018-10-23 | 成都倍特药业有限公司 | 用作布鲁顿酪氨酸激酶抑制剂的化合物及其制备方法和应用 |
TW201927769A (zh) * | 2017-12-18 | 2019-07-16 | 德商歌林達有限公司 | 經取代之吡咯啶醯胺ii |
WO2020254552A2 (en) | 2019-06-19 | 2020-12-24 | Grünenthal GmbH | Substituted pyrrolidine amides v |
KR20230107801A (ko) * | 2020-09-30 | 2023-07-18 | 에프엘2022-001, 인코포레이티드 | Hsd17b13 억제제 및 이의 용도 |
-
2021
- 2021-06-21 AU AU2021296163A patent/AU2021296163A1/en active Pending
- 2021-06-21 KR KR1020237002370A patent/KR20230027245A/ko unknown
- 2021-06-21 US US17/353,567 patent/US11787780B2/en active Active
- 2021-06-21 BR BR112022026201A patent/BR112022026201A2/pt unknown
- 2021-06-21 CA CA3187566A patent/CA3187566A1/en active Pending
- 2021-06-21 IL IL298957A patent/IL298957A/en unknown
- 2021-06-21 WO PCT/US2021/038218 patent/WO2021262587A1/en unknown
- 2021-06-21 CN CN202180050361.5A patent/CN116113627A/zh active Pending
- 2021-06-21 MX MX2022016445A patent/MX2022016445A/es unknown
- 2021-06-21 EP EP21828279.6A patent/EP4168402A1/en active Pending
- 2021-06-21 JP JP2022578812A patent/JP2023535279A/ja active Pending
- 2021-06-22 TW TW110122726A patent/TWI811710B/zh active
-
2023
- 2023-01-19 CO CONC2023/0000627A patent/CO2023000627A2/es unknown
- 2023-08-11 US US18/448,696 patent/US20240150320A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230032612A1 (en) | 2023-02-02 |
EP4168402A1 (en) | 2023-04-26 |
WO2021262587A1 (en) | 2021-12-30 |
CA3187566A1 (en) | 2021-12-30 |
CN116113627A (zh) | 2023-05-12 |
AU2021296163A1 (en) | 2023-02-02 |
TW202208350A (zh) | 2022-03-01 |
MX2022016445A (es) | 2023-02-01 |
JP2023535279A (ja) | 2023-08-17 |
TWI811710B (zh) | 2023-08-11 |
US11787780B2 (en) | 2023-10-17 |
CO2023000627A2 (es) | 2023-04-17 |
KR20230027245A (ko) | 2023-02-27 |
US20240150320A1 (en) | 2024-05-09 |
IL298957A (en) | 2023-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022026201A2 (pt) | Antagonistas do receptor de glicocorticoide de indazol quaternários | |
CO2019013021A2 (es) | Amidas de piridona deuteradas y sus profármacos como moduladores de los canales de sodio | |
ECSP20053845A (es) | Macrociclos como moduladores del regulador de conductancia transmembrana de la fibrosis quística, composiciones farmacéuticas de estos, su uso en el tratamiento de la fibrosis quística y procesos para elaborarlos | |
UY39296A (es) | Azaquinolonas sustituidas inhibidoras de parp y composiciones farmacéuticas que las contienen | |
CL2021000191A1 (es) | Inhibidores de inflamasoma nlrp3 | |
CO2019010078A2 (es) | Compuestos de pirimidinil-pyridiloxi-naftil y métodos para tratar enfermedades y trastornos relacionados con ire1 | |
AU2019262169B2 (en) | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORy) and pharmaceutical uses thereof | |
BR112018007947A2 (pt) | uso de antagonistas de receptor ep4 para o tratamento de câncer de fígado associado a nash | |
CL2012000925A1 (es) | Compuestos derivados de tetrahidrociclohepta[b]piridinilo, antagonista del receptor de cgrp; composicion farmaceutica que lo comprende; y su uso en el tratamiento de migraña, cefalea, diabetes, cancer, entre otras. | |
DE602008005582D1 (de) | Pyrazolderivate als p2x7-modulatoren | |
MA41389A1 (fr) | Utilisation de sulfones tricycliques en tant que modulateurs de rory | |
BR112020007589A8 (pt) | Derivados de benzimidazol e seus usos | |
CL2019003274A1 (es) | Derivados de pirimidina como moduladores del receptor de pge2. | |
CR20190379A (es) | Moduladores del receptor de estrógeno | |
ECSP21037191A (es) | Pirazoles como moduladores de la hemoglobina | |
MX2023000677A (es) | Compuestos moduladores de receptor de estrogeno. | |
CL2022001675A1 (es) | Derivados de benzimidazol | |
CL2023001755A1 (es) | Compuestos farmacéuticos. | |
ECSP21060917A (es) | Formulación de anticuerpos terapéuticos | |
CL2015003761A1 (es) | Derivados de etinil como antagonistas de receptor metabotrópico de glutamato. | |
ECSP19019589A (es) | Compuestos de indazol para usar en lesiones de tendones y/o ligamentos | |
TN2012000563A1 (fr) | Nouvelle association entre le 4(3-(cis-hexahydrocyclopenta(c)pyrrol-2(1-h)-yl)propoxy)benzamide et un antagoniste des recepteurs nmda et les compositions pharmaceutiques qui la contiennent. | |
CO2023014012A2 (es) | Derivados de tetrahidrotieno piridina como inhibidores de ddr | |
EA202090982A1 (ru) | Производные бензимидазола и варианты их применения | |
TR201109516A2 (tr) | 5ht1 reseptör agonisti/nsaid kombinasyonun migren tedavisinde farmasötik formülasyonları. |